🚀 Join us at ESMO 2025! 🚀 Today we will be presenting poster FPN 550P: "Retrospective analysis of molecular resistance biomarkers to trastuzumab deruxtecan (T-DXd) in metastatic breast cancer (mBC)" 📍 : Poster Area, ESMO 2025 🕛 : Today at 12:00 PM #ESMO2025 #BreastCancer

Incredible week at the CCE Summer School in Translational Cancer Research in Algarve! 🌊 Grateful for the chance to learn, connect, and get inspired by brilliant minds in cancer research. Thanks to @cancercoreeurope.bsky.social & @gustaveroussy.fr for the opportunity! #CancerResearch #Oncology

📢 Join us at #ESMOBC25 today at 12:00 in the Poster Area! 🧬 154P – Young BRCA+ TNBC: outcomes by histology 💊 353P – Post–T-DXd strategies in HER2+ mBC I’ll be next to poster 353P and happy to discuss both. Stop by for a chat! #BreastCancer #Oncology #TNBC #HER2 #ESMOBC

🧬 Just out! Our review on radioligand therapy in mBC is now published in Cancer Treatment Reviews. Huge thanks to the whole team, especially Carmen Criscitiello for her mentorship. 🔗 doi.org/10.1016/j.ct... #breastcancer #RLT #precisionmedicine #theranostics #nuclearmedicine #oncology